VINC - Vincerx Pharma, Inc.
0.1
-0.033 -33.300%
Share volume: 4,482,550
Last Updated: 04-22-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.13
-0.03
-0.25%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-12-2024 | 03-27-2025 | 05-15-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | ||||
| Operating expenses | 7.478 M | 7.366 M | 7.793 M | 8.826 M | 3.334 M | |
| Selling general and admin | 2.922 M | 3.612 M | 3.885 M | 5.558 M | 2.316 M | |
| Research and development | 4.556 M | 3.754 M | 3.908 M | 3.268 M | 1.018 M | |
| Total expenses | 7.478 M | 7.366 M | 7.793 M | 8.826 M | 3.334 M | |
| -1.50% | 5.80% | 13.26% | -62.23% | |||
| Operating income | -7.478 M | -7.366 M | -7.793 M | -8.826 M | -3.334 M | |
| Ebit | -12.528 M | -1.965 M | -7.997 M | -8.056 M | -5.000 M | |
| Pretax income | -12.429 M | -1.808 M | -7.843 M | -7.994 M | -5.000 M | |
| -85.45% | 333.79% | 1.93% | -37.45% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -12.429 M | -1.808 M | -7.843 M | -7.994 M | -5.000 M | |
| 85.45% | -333.79% | -1.93% | 37.45% |